Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shin-Ichi Harashima

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 28, 2015
[DPP-4 inhibitor]Shin-Ichi Harashima, Nobuya Inagaki
Expert Opinion on Pharmacotherapy|November 17, 2016
Attitudes of patients and physicians to insulin therapy in Japan: an analysis of the Global Attitude of Patients and Physicians in Insulin Therapy studyShin-Ichi Harashima, Akiko Nishimura, Nobuya Inagaki
Expert Opinion on Pharmacotherapy|May 26, 2018
Canagliflozin for the treatment of type 2 diabetes: a comparison between Japanese and non-Japanese patientsNobuya Inagaki, Shin-Ichi Harashima, Hiroaki Iijima
Metabolic Syndrome and Related Disorders|July 16, 2020
Overeating Risk in Overweight Young Women Is Divided into Two Types According to Appetite and Eating BehaviorAkiko Nishimura, Shin-Ichi Harashima, Kiminori Hosoda, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 28, 2018
Long-Term Effect of the Color Record Method in Self-Monitoring of Blood Glucose on Metabolic Parameters in Type 2 Diabetes: A 2-Year Follow-up of the Color IMPACT StudyAkiko Nishimura, Shin-Ichi Harashima, Kiminori Hosoda, et al.
Molecular and Cellular Endocrinology|October 6, 2009
IA-2 modulates dopamine secretion in PC12 cellsTakuya Nishimura, Shin-Ichi Harashima, Hu Yafang, et al.
Rheumatology (Oxford, England)|March 3, 2010
Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agentsTakahiko Horiuchi, Hiroki Mitoma, Shin-ichi Harashima, et al.
Therapeutic Advances in Endocrinology and Metabolism|March 13, 2019
Sex-related differences in frailty factors in older persons with type 2 diabetes: a cross-sectional studyAkiko Nishimura, Shin-Ichi Harashima, Kiminori Hosoda, et al.
Acta Haematologica|May 16, 2003
Successful treatment of invasive pulmonary aspergillosis by transbronchial injection of urinary trypsin inhibitor and amphotericin BShin-ichi Harashima, Hisorhi Tsukamoto, Hiroaki Nishizaka, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2005
The dense core transmembrane vesicle protein IA-2 is a regulator of vesicle number and insulin secretionShin-ichi Harashima, Anne Clark, Michael R Christie, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 28, 2015
[DPP-4 inhibitor]Shin-Ichi Harashima, Nobuya Inagaki
Expert Opinion on Pharmacotherapy|November 17, 2016
Attitudes of patients and physicians to insulin therapy in Japan: an analysis of the Global Attitude of Patients and Physicians in Insulin Therapy studyShin-Ichi Harashima, Akiko Nishimura, Nobuya Inagaki
Expert Opinion on Pharmacotherapy|May 26, 2018
Canagliflozin for the treatment of type 2 diabetes: a comparison between Japanese and non-Japanese patientsNobuya Inagaki, Shin-Ichi Harashima, Hiroaki Iijima
Metabolic Syndrome and Related Disorders|July 16, 2020
Overeating Risk in Overweight Young Women Is Divided into Two Types According to Appetite and Eating BehaviorAkiko Nishimura, Shin-Ichi Harashima, Kiminori Hosoda, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 28, 2018
Long-Term Effect of the Color Record Method in Self-Monitoring of Blood Glucose on Metabolic Parameters in Type 2 Diabetes: A 2-Year Follow-up of the Color IMPACT StudyAkiko Nishimura, Shin-Ichi Harashima, Kiminori Hosoda, et al.
Molecular and Cellular Endocrinology|October 6, 2009
IA-2 modulates dopamine secretion in PC12 cellsTakuya Nishimura, Shin-Ichi Harashima, Hu Yafang, et al.
Rheumatology (Oxford, England)|March 3, 2010
Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agentsTakahiko Horiuchi, Hiroki Mitoma, Shin-ichi Harashima, et al.
Therapeutic Advances in Endocrinology and Metabolism|March 13, 2019
Sex-related differences in frailty factors in older persons with type 2 diabetes: a cross-sectional studyAkiko Nishimura, Shin-Ichi Harashima, Kiminori Hosoda, et al.
Acta Haematologica|May 16, 2003
Successful treatment of invasive pulmonary aspergillosis by transbronchial injection of urinary trypsin inhibitor and amphotericin BShin-ichi Harashima, Hisorhi Tsukamoto, Hiroaki Nishizaka, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2005
The dense core transmembrane vesicle protein IA-2 is a regulator of vesicle number and insulin secretionShin-ichi Harashima, Anne Clark, Michael R Christie, et al.
Pageof 6